Chemical Constituents of Schefflera Venulosa and Their Antitumor Activities

LIU Rui,GU Qian-qun,CUI Cheng-bin,HAN Bing,CAI Bing,LIU Hong-bing
DOI: https://doi.org/10.3321/j.issn:0253-2670.2005.03.003
2005-01-01
Abstract:Objective To investigate the antitumor constituents from Schefflera venulosa, a Chinese folk medicine used for the treatment of cancer. Methods Bioactive fractions were obtained from the crude extract of S. venulosa, and the chemical constituents of the fraction were investigated to obtain pure compounds by the combined use of column chromatography over Sephadex LH-20 method. The structures of the obtained compounds were elucidated by spectroscopic method and the antitumor activities were assayed using mouse tsFT210 cells and K562 cell line by flow cytometry and SRB method. Results Nine pure compounds were isolated from the bioactive fractions of the crude extract of S. venulosa and they were identified as 2-hydroxy-3-(phenylaminocarbonyl)naphthalene-1-azobenzene (Ⅰ), chrysophanol (Ⅱ), 2, 6-dimetmoxyl p-benzoquinone (Ⅲ), n-hexadecanoic acid (Ⅳ), n-stearic acid (Ⅴ), n-hexacosnic acid (Ⅵ), stigmasta-4, 22-dien-3-one (Ⅶ), 3β-hydroxystigmasta-5, 22-dien-7-one (Ⅷ), β-sitosterol (Ⅸ), respectively. Among them, Ⅱ and Ⅲ inhibited the K562 cells with IC 50 (52.50 and 25.50 μg/mL), respectively, and compound Ⅳ inhibited the cell cycle of tsFT210 cells at the G 2/M phase. Conclusion Compound Ⅰ is a new natural product named as 808 Scarlet and Ⅱ-Ⅷ are isolated from S. venulosa for the first time. The antitumor activity of compound Ⅲ has been found first. Compounds Ⅱ-Ⅳ provide the first example of antitumor constituents of the same plant.
What problem does this paper attempt to address?